HCV - Research

Research
Double-Blinded Study In Patients With Compensated Cirrhosis Due To Chronic Hepatitis C Who Are Non-Responders To Prior Interferon Alfa Or interferon Alfa

Hepatitis C and Complementary and Alternative Medicine: 2003 Update
National Institute of Diabetes and Digestive and Kidney Diseases. Chronic Hepatitis C: Disease Management . National Institute of Diabetes and Digestive and Kidney Diseases Web site. Accessed at

NEJM -- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients Francesca J. Torriani, M.D., Maribel Rodriguez-Torres, M.D., J rgen K. Rockstroh, M.D., Eduardo

Harvard Medical School - Online CME
Chronic hepatitis C afflicts 170 million individuals worldwide and is a major cause of morbidity and mortality. We discuss the various modes of acquisition of hepatitis C. Although cirrhosis and its

HepNet: Hepatitis C: TREATING YOUR CHRONIC HEPATITIS B OR C
For chronic hepatitis C, it may take as long as 2 years. Q. Does treatment with interferon ever have to be repeated? A. Some people with either chronic hepatitis B or C may have a relapse, or return

}
SUSTAINED ALT RESPONSE RATE VS DURATION OF THERAPY IN CHRONIC HEPATITIS C PATIENTS INTRON A 3 Million IU TIW Treatment Group* Number of Patients (%) INTRON A 3 million IU Difference